Abvc Biopharma (ABVC) Other Accumulated Expenses (2010 - 2026)
Abvc Biopharma (ABVC) posted Other Accumulated Expenses of $569,732 for Q2 2026, down 86.7% from $4.29 million a year earlier but up 8.8% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Other Accumulated Expenses came in at $470,133, up 9.3% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -32.6% (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Other Accumulated Expenses was $430,107 in FY2024, $38,819 in FY2023 (-91.7%), $468,150 in FY2022 (-90.3%) and $4.84 million in FY2021 (+43.4%).
- Quarterly Other Accumulated Expenses has run from a low of $3,613 in Q1 2023 to a high of $5.4 million in Q1 2022 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in three of the last six quarters, with growth averaging 28.4%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2025, with growth of 312.4%; the weakest was Q1 2023, with a decline of 99.9%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $523,853 (Q1 2026), $470,133 (Q4 2025) and $575,578 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Abvc Biopharma | 26.03 Mn | 28.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 569,732.00 |
| Mar 31, 2026 | 523,853.00 |
| Dec 31, 2025 | 470,133.00 |
| Sep 30, 2025 | 575,578.00 |
| Jun 30, 2025 | 4.29 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 430,107.00 |
| Sep 30, 2024 | 452,390.00 |
| Jun 30, 2024 | 325,090.00 |
| Mar 31, 2024 | 927,883.00 |
| Dec 31, 2023 | 38,819.00 |
| Sep 30, 2023 | 480,196.00 |
| Mar 31, 2023 | 3,613.00 |
| Dec 31, 2022 | 468,150.00 |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Dec 31, 2019 | 32,905.00 |
| Sep 30, 2019 | 154,029.00 |
| Dec 31, 2018 | 5,758.00 |
API Access
Abvc Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();